Skip to main content
Premium Trial:

Request an Annual Quote

Posters, Please!

Nature Chemistry's Neil Withers can't imagine attending meetings without poster sessions. "This is surely testament to the power of the humble poster: They are the places to see the newest science and talk to the people who actually do the work in the lab," he says at The Skeptical Chymist.

To have an effective poster, Withers says that "clarity on content are key." He recommends thoroughly considering the audience before putting the poster together. "When presenting your poster to other delegates, finding out what level of background knowledge they have will mean you pitch it at the right level and gives you the chance to create a dialogue" — which, Withers adds, is the point of the poster session. "One of the key attractions of most poster sessions is the opportunity to talk to the people. ... As networking events, poster sessions are unequalled at most scientific meetings: relaxed and full of opportunities to bump into people who might make the ideal advisor for that post-doctoral position you were looking for — and vice versa," he says.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.